Add like
Add dislike
Add to saved papers

Experimental investigation of the inerting effect of crystalline II type Ammonium Polyphosphate on explosion characteristics of micron-size Acrylates Copolymer dust.

The inerting effect of crystalline II type Ammonium Polyphosphate (APP-II) on explosion characteristics of micron-size Acrylates Copolymer (ACR) powders was experimentally studied. The inerting mechanism was analysed by combining thermogravimetry (TG) and differential scanning calorimetry (DSC) tests. The results indicated that the maximum explosion pressure (Pmax ) and explosion index (Kst ) was 10.4bar and 416bar m/s, respectively for ACR powders. The minimum explosion concentration (MEC) of ACR powders ranged from 20 to 30g/m3 , and the experimental minimum ignition energy (MIE) of the ACR dust cloud was 10mJ. Therefore, ACR dust was determined to be severely combustible dust. There existed a minimum inerting concentration (MIC), and the explosion of ACR powders can be inerted completely by 80wt% APP-II. Furthermore, 30 and 40wt% APP-II had a significant inerting effect on the MIE of ACR dust. According to TG and DSC tests, thermal stability of ACR would be augmented by the introduction of APP-II. The addition of APP-II triggered lower maximum mass loss rate (MMLR), higher temperature corresponding to mass loss of 90% (T0.1 ), chars yield, and endothermic peaks. Consequently, the ACR dust explosion was inerted by the chemical interaction of ACR/APP-II mixtures and endothermic decomposition of APP-II.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app